Third INTERMACS Annual Report: The evolution of destination therapy in the United States
Third INTERMACS Annual Report: The evolution of destination therapy in the United States
复制标题
DOI：
10.1016/j.healun.2010.12.001
复制
发表时间：
2011-02-01
影响因子：
8.9
通讯作者：
Young, James B.
中科院分区：
文献类型：
--
作者：
Kirklin, James K.;Naftel, David C.;Young, James B.
机械辅助循环支持机构间登记处 (INTERMACS) 的第三份年度报告提供了美国耐用机械循环支持当前状况的记录。随着近 3,000 名患者进入数据库，向连续流泵技术的过渡是显而易见且引人注目的。本报告重点关注以机械循环支持作为目标治疗的快速扩展的经验。目前连续流目的地治疗的 I 年生存率为 75%，为该疗法的不断发展应用提供了基准。 J Heart Lung Transplant 2011；30:115-23 (C) 2011 国际心肺移植学会。版权所有。
The third annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) provides documentation of the current landscape of durable mechanical circulatory support in the United States. With nearly 3,000 patients entered into the database, the transition to continuous-flow pump technology is evident and dramatic. This report focuses on the rapidly expanding experience with mechanical circulatory support as destination therapy. The current I-year survival of 75% with continuous-flow destination therapy provides a benchmark for the evolving application of this therapy. J Heart Lung Transplant 2011;30:115-23 (C) 2011 International Society for Heart and Lung Transplantation. All rights reserved.